Prostate Cancer - Results from #260

A multidisciplinary approach to optimize primary prostate cancer biobanking. May 3, 2022

Radiotherapy plus androgen-deprivation therapy for PSA persistence in lymph node-positive prostate cancer. May 2, 2022

Incidence of grade 3-4 adverse events, dose reduction and treatment discontinuation in castration-resistant prostate cancer patients receiving PARP inhibitors: a meta-analysis. May 2, 2022

Systematic review of sleep and sleep disorders among prostate cancer patients and caregivers: a call to action for using validated sleep assessments during prostate cancer care. May 2, 2022

Interventions for obstructive uropathy in advanced prostate cancer: a population-based study. May 2, 2022

Event-free survival after radical prostatectomy according to PSMA PET and EAU Biochemical Recurrence Risk Groups. May 2, 2022

NCCN Risk Reclassification in Black Men with Low and Intermediate Risk Prostate Cancer After Genomic Testing. May 1, 2022

The impact of age on prostate cancer progression and quality of life in active surveillance patients. April 29, 2022

Increased body mass index is associated with operative difficulty during robot-assisted radical prostatectomy. April 29, 2022

Oligorecurrent nodal prostate cancer: radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial. April 29, 2022

Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians. April 29, 2022

Robotic prostatectomy after abandoned open radical prostatectomy-Technical aspects and outcomes. April 29, 2022

Impact of New Systemic Therapies in Overall Survival in Non-Metastatic Castration Resistant Prostate Cancer: Systematic Review and Meta-Analysis. April 29, 2022

ASCL1 Activates Neuronal Stem Cell-like Lineage Programming Through Remodeling of the Chromatin Landscape in Prostate Cancer April 28, 2022

Cost-effectiveness of enzalutamide versus apalutamide versus androgen deprivation therapy alone for the treatment of metastatic castration-sensitive prostate cancer in Canada. April 28, 2022

A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome. April 28, 2022

Prostate Cancer with Peritoneal Carcinomatosis: A robotic-assisted radical prostatectomy-based Case Series. April 28, 2022

The cost impact of disease progression to metastatic castration-sensitive prostate cancer. April 28, 2022

High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. April 28, 2022

Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016. April 28, 2022

Page 14 of 1232

email news signup